Mark J. Pierson
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune responses and vaccinations
- Aging top 10%
Papers in
- Immunology 12
- T-cell and B-cell Immunology 7
- IL-33, ST2, and ILC Pathways 1
- Immune Cell Function and Interaction 1
-
- Glaucoma and retinal disorders 1
- Retinal Diseases and Treatments 1
- Co-authors
- David Masopust (11 shared papers)Lalit K. Beura (6 shared papers)Vaiva Vezys (8 shared papers)Sathi Wijeyesinghe (5 shared papers)Pamela C. Rosato (2 shared papers)Sara E. Hamilton (11 shared papers)Neal D. Heuss (5 shared papers)Dale S. Gregerson (5 shared papers)
- Journals
- The Journal of Immunology (4 papers)Journal of Neuroinflammation (3 papers)Cell Reports (3 papers)The Journal of Experimental Medicine (2 papers)Immunity (2 papers)
- Partner nations
- United StatesJapanNorway
In The Last Decade
Mark J. Pierson
29 papers receiving 1.1k citations
Mark J. Pierson's Hit Papers
Peers
Comparison fields: 5 of 62
- Immunology 335
- Aging 18
- Ophthalmology 73
- Physiology 116
- Neurology 20
Countries citing papers authored by Mark J. Pierson
This map shows the geographic impact of Mark J. Pierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Pierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Pierson more than expected).
Fields of papers citing papers by Mark J. Pierson
This network shows the impact of papers produced by Mark J. Pierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Pierson. The network helps show where Mark J. Pierson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Pierson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Senolytics reduce coronavirus-related mortality in old mice Hit paper breakdown → | 2021 | 271 |
| 2 | 2018 | 206 | |
| 3 | 2021 | 107 | |
| 4 | 2019 | 91 | |
| 5 | 2020 | 78 | |
| 6 | 2021 | 54 | |
| 7 | 2018 | 46 | |
| 8 | 2014 | 38 | |
| 9 | Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. | 1996 | 23 |
| 10 | 2014 | 23 | |
| 11 | 2024 | 23 | |
| 12 | 2022 | 21 | |
| 13 | 2017 | 18 | |
| 14 | 2021 | 18 | |
| 15 | 2023 | 18 | |
| 16 | 2019 | 17 | |
| 17 | 2024 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2024 | 10 |
About Mark J. Pierson
Mark J. Pierson is a scholar working on Immunology, Ophthalmology, Physiology, Genetics and Epidemiology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (7 papers), Evolution and Genetic Dynamics (1 paper), Telomeres, Telomerase, and Senescence (1 paper), Glaucoma and retinal disorders (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Immune Cell Function and Interaction (1 paper), Influenza Virus Research Studies (1 paper) and Retinal Diseases and Treatments (1 paper). The work is most often cited by research in Immunology (335 citations), Aging (18 citations), Ophthalmology (73 citations), Physiology (116 citations) and Neurology (20 citations). Mark J. Pierson has collaborated with scholars based in United States, Japan and Norway. Frequent co-authors include David Masopust, Lalit K. Beura, Vaiva Vezys, Sathi Wijeyesinghe, Pamela C. Rosato, Sara E. Hamilton, Neal D. Heuss, Dale S. Gregerson, Thomas S. Griffith and Scott W. McPherson. Their work appears in journals such as The Journal of Immunology, Journal of Neuroinflammation, Cell Reports, The Journal of Experimental Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.